Rockefeller Capital Management L.P. Boosts Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Rockefeller Capital Management L.P. lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 17.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 188,279 shares of the company's stock after purchasing an additional 27,838 shares during the period. Rockefeller Capital Management L.P. owned 1.25% of U.S. Physical Therapy worth $16,702,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of USPH. CBIZ Investment Advisory Services LLC lifted its position in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after purchasing an additional 122 shares during the period. Venturi Wealth Management LLC lifted its holdings in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after buying an additional 704 shares during the period. Pacer Advisors Inc. bought a new stake in U.S. Physical Therapy during the 4th quarter valued at approximately $113,000. Mutual of America Capital Management LLC purchased a new position in shares of U.S. Physical Therapy during the 4th quarter worth approximately $203,000. Finally, KLP Kapitalforvaltning AS purchased a new position in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $257,000.

U.S. Physical Therapy Stock Down 1.7 %

Shares of USPH traded down $1.18 on Friday, hitting $67.28. 90,376 shares of the stock traded hands, compared to its average volume of 106,533. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $108.14. The company has a market capitalization of $1.02 billion, a PE ratio of 71.57, a P/E/G ratio of 3.54 and a beta of 1.38. The business has a 50 day simple moving average of $76.43 and a 200 day simple moving average of $84.81. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million during the quarter, compared to analysts' expectations of $173.10 million. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.68%. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date was Friday, March 14th. U.S. Physical Therapy's payout ratio is presently 97.83%.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of research reports. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research decreased their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. StockNews.com lowered shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Thursday. Finally, JPMorgan Chase & Co. decreased their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Wednesday, March 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is owned by insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.